|Home | About | Journals | Submit | Contact Us | Français|
While the emergency department (ED) is often a first point of entry for children and youth with mental health (MH) concerns, there is a limited capacity to respond to MH needs in this setting. Child MH systems are typically fragmented among multiple ministries, organizations, and providers. Communication among these groups is often poor, resulting in gaps, particularly in transitions of care, for this vulnerable population. The evidence-based Emergency Department Mental Health Clinical Pathway (EDMHCP) was created with two main goals: (1) to guide risk assessment and disposition decision-making for children and youth presenting to the ED with MH concerns and (2) to provide a streamlined transition to follow-up services with community MH agencies (CMHAs) and other providers. The purpose of this paper is to describe our study protocol to implement and evaluate the EDMHCP.
This mixed methods health services research project will involve implementation and evaluation of the EDMHCP in four exemplar ED-CMHA dyads. The Theoretical Domains Framework will be used to develop a tailored intervention strategy to implement the EDMHCP. A multiple baseline study design and interrupted time-series analysis will be used to determine if the EDMHCP has improved health care utilization, medical management of the MH problems, and health sector coordination. The primary process outcome will be the proportion of patients with MH-specific recommendations documented in the health record. The primary service outcome will be the proportion of patients receiving the EDMHCP-recommended follow-up at 24-h or at 7 days. Data sources will include qualitative interviews, health record audits, administrative databases, and patient surveys. A concurrent process evaluation will be conducted to assess the degree of variability and fidelity in implementation across the sites.
This paper presents a novel model for measuring the effects of the EDMHCP. Our development process will identify how the EDMHCP is best implemented among partner organizations to deliver evidence-based risk management of children and youth presenting with MH concerns. More broadly, it will contribute to the body of evidence supporting clinical pathway implementation within novel partnerships.
Approximately 80 % of children and youth with mental health (MH) problems do not receive any MH services [1–3]. However, this seems to be impacting emergency departments (EDs), which are a commonly used access point for care. Due to the scarcity of child and youth MH services, EDs have increasingly become the place that families present for help. In its baseline scorecard for child and youth MH within Ontario, Canada, the Institute for Clinical Evaluative Sciences (ICES) reported marked annual increases in ED presentations between 2009 and 2012 among youth for anxiety, mood, and substance abuse disorders . At one Canadian ED, visits for MH concerns among children and youth increased, more than 50 % increase from 2010 to 2011 , far exceeding the 15 % increase in overall patient visits documented in the hospital administrative database.
Although families attempt to access treatment and services in these settings, EDs are ill equipped to manage these pediatric MH problems. EDs typically lack standardized MH screening tools and pediatric MH expertise. In addition, with the complex and fragmented MH systems across North America [3, 6], many EDs lack defined, reliable, and integrated referral processes to appropriate community resources. Therefore, ED clinicians have difficulty identifying the appropriate MH services to which to refer patients for follow-up care .
To address these concerns, a group of Canadian hospital and community-based professionals was commissioned by the Provincial Council on Maternal Child Health in Ontario to create a clinical pathway, known as the Emergency Department Mental Health Clinical Pathway (EDMHCP) for children and youth presenting with MH problems (see Fig. 1). The EDMHCP is designed to (i) improve early identification and intervention for CYMH issues, (ii) provide more timely access to community MH services, and (iii) reduce service gaps for vulnerable children and youth. It defines a standardized approach to risk assessment and disposition decision-making and while improving access to appropriate needs-based MH care . Finally, the EDMHCP aims to provide a seamless transition of care for children/youth and caregivers between the ED, outpatient hospital services and community MH agencies (CMHA), with tailored linkages to community resources through the HEADS-ED screening tool  incorporated within the pathway.
The overall aim of our project is to implement and evaluate impact of the EDMHCP in specific settings and to evaluate the implementation process. The purpose of this paper is to document the protocol for this 3-year mixed methods health services research project. Research objectives for this study are to:
The protocol for this MH project was adapted from a recent ED clinical pathway implementation protocol . Collaborating with site partners, a theory-based and tailored intervention strategy will be developed to implement the EDMHCP within each ED-CMHA dyad. A concurrent process evaluation will be conducted to assess the implementation strategy. For this protocol, we completed the CONSORT 2010 checklist for randomized trials .
To assess EDMHCP feasibility in various settings, implementation will occur in a staggered process in four Ontario exemplar ED-CMHA dyads with different patient populations and workflows that do not currently utilize clinical pathways. Our exemplar ED sites include a pediatric specialized center with an annual patient census of 70,000, a high-volume community urban hospital (annual patient census 75,000), a low-volume rural hospital (annual patient census 25,000), and a high-volume general hospital in a smaller community (annual patient census 60,000).
To begin, commitment to the implementation intervention by an administrative lead on behalf of each hospital and CMHA will be required. The EDMHCP has specific inclusion/exclusion criteria for patients presenting to the ED, which may be modified at each site based on organizational requirements. Inclusion criteria for patient participants include (1) ages ≥6 and <18 years, (2) ED presentation within a selected 8-month implementation period, (3) MH presenting complaint, and 4) proficiency in English or French. Exclusion criteria include (1) highest priority triage designation (resuscitation), (2) medically unstable patients, (3) intubation/intensive care required, and (4) direct admission to hospital for ongoing medical management and observation. Patients who are stable but require medical management are eligible for the pathway once they are clinically able to participate in a MH assessment in the ED (see Fig. 1).
Participants within each study site include ED staff and physicians, CMHA clinicians, and administrators, as well as patients (and their caregivers) presenting with MH concerns. Site champions will be identified for optimal local implementation.
As illustrated in Fig. 2, our intervention strategy will build on core components with findings from site visits and qualitative interview findings to identify relevant behavior change techniques for our tailored intervention strategy.
Based on experience in related provincial and regional implementations [12–15], we have provisionally selected core intervention components, as listed in Table 1. Engagement of respected and influential champions at each site is a critical element in promoting and maintaining local interest in the pathway. Additional components include education sessions, website support, posters, and reminders. Currently, an implementation toolkit for the EDMHCP is readily available online (http://www.pcmch.on.ca/health-care-providers/paediatric-care/pcmch-strategies-and-initiatives/ed-clinical-pathways/) . These instructions, measures, and training materials will be tailored for each site and hosted online during the implementation phase on the HEADS-ED website . While the study team will provide guidance and ongoing support, site members will deliver relevant activities to ensure a realistic assessment of requirements for this and future implementations.
Further aspects of our intervention strategy will be based on the Theoretical Domains Framework (TDF), which consists of a set of conceptual determinants and associated theoretical constructs that are believed to influence behavior and stimulate behavior change [17, 18]. The TDF provides a useful approach to identifying relevant behavioral determinants and designing interventions that will address these . We have successfully conducted TDF-based focus groups with various urban and rural ED teams on implementing the HEADS-ED screening tool , an integral component of the EDMHCP. For this study, additional TDF focus groups, with up to 10 participants, will be conducted at each CMHA to elicit perceptions related to adopting the EDMHCP. Further guiding our strategy, we will assess organizational readiness and relevant factors for change through TDF-guided key informant (KI) interviews with one administrator at each site. All interviews will be audiotaped and transcribed for analysis.
Implementation will begin with site visits to further assess organizational issues within CMHAs and EDs, such as intake and flow of pediatric patients, specific and shared roles of health providers, and pathway fit and acceptability. Infrastructure requirements and implementation readiness will also be assessed. A structured site visit form will be used to take notes and guide visits at each ED or CMHA.
We will conduct a mapping exercise to link relevant behavioral determinants among health providers identified through the qualitative interviews. We will then tailor our core strategy by applying known taxonomies of behavior change techniques [20, 21] to identify and select appropriate modes of delivery for a multifaceted intervention strategy that would go beyond simply educating for change. For example, methods may include facilitation, nudging, or systems change. Feasibility and practicality will be important considerations to ensure implementation success.
Ongoing support will be provided to expedite pathway implementation and mitigate delays due to other organizational priorities. We will communicate monthly with site champions to support progress during implementation and every 2 months in the post-implementation phase to ensure sustainability. The project coordinator will communicate regularly to ensure target dates are met, using a process log to track reasons for delays that will be explored further in the post-implementation interviews.
The project phases and designated timelines are outlined in Table 2. Once REB approval is secured at each site, the pre-implementation phase will proceed with the site readiness visits and qualitative interviews that will determine the final tailored intervention strategies. The implementation phase for each dyad begins with a process to secure a written memorandum agreement between the ED and CMHA to ensure clarity of responsibilities and expectations integral to the pathway. Implementation will proceed as per the tailored intervention strategy. Completed pathway implementation requires, at a minimum, the following: EDMHCP site customization and committee approvals, delivery of at least two educational workshops for each organization, and EDMHCP availability in the ED. We have designated an 8-month period for EDMHCP implementation within each dyad. Following initiation within the first dyad, subsequent dyads will begin implementation in a staggered pattern every 3 months to allow for optimal study team support and incorporating learning from experience with previous dyads. In the post-implementation phase, qualitative interviews will explore experience with the implementation and site audits will be done to assess implementation status. We have defined the data collection periods as follows: (i) post-implementation, as the consecutive 9-month span that follows implementation completion plus an initial 3-month “settling in” time and (ii) pre-implementation, as a similar 9-month span prior to the intervention.
To assess the impact of the EDMHCP implementation and explore the factors leading to our eventual findings, we have planned a mixed methods evaluation approach employing both quantitative and qualitative evaluations, as summarized in Table 3 and described further below. Additionally, a concurrent process evaluation will be conducted to assess the degree of variability and fidelity in implementation of the intervention within each dyad. This evaluation will include a process log, post-implementation site visits, and qualitative interviews.
Table 4 provides a summary of study outcomes with the corresponding evaluation measures. The primary process outcome is the proportion of patients with documented MH-specific recommendations, as defined by the project team and based on the EDMHCP, in the medical chart. The primary MH service outcome is the proportion of patients that receive the EDMHCP recommended follow-up: either within 24 h or 7 days post-ED visit, based on pathway defined risk level. Recognizing logistic and scheduling factors, a successful outcome will permit a 12-h or 3-day window for follow-up. Adherence, within-window adherence, and non-adherence will be analyzed separately. Secondary outcomes include (1) EDMHCP uptake in the ED, measured as the proportion of completed clinical pathway forms filed in the health record; (2) post-ED uptake of recommended community MH services, as measured by the Services for Children and Adolescent-Parent Interview (SCA-PI) tool ; (3) alignment of recommended services to the HEADS-ED assessment; (4) ED length of stay, hospital admissions, ED revisits (10 days and 3 months) obtained from health records and National Ambulatory Care Reporting System (NACRS) data; and (5) patient/caregiver satisfaction with the ED visit as measured by the Services for Children and Adolescent-Parent Interview (SCA-PI)  and the Client Satisfaction Questionnaire (CSQ-8) .
To evaluate whether the intervention results in EDMHCP use among ED clinicians and documentation of MH-specific discharge recommendations, we will audit health records of relevant patients seen during alternate weeks in each 9-month pre- and post-implementation period. ICD10 codes (F codes, mental, and behavior disorders; X codes, intentional self-poisoning and self-harm; Y codes, poisoning and self-harm of undetermined intent) listed as primary or secondary diagnoses will identify relevant patient charts during the study period. Abstracted data will include demographic and sufficient clinical data to determine risk assessment, disposition plans, and adherence with EDMHCP recommendations. Two auditors, blinded to the study aims and protocol, will be trained to abstract and directly enter health records data into REDCap, an online database . A data dictionary will be created to guide auditors and ensure standardized data collection procedures. Auditors will each abstract the same 50 charts to assess inter-rater agreement. This will be measured for key variables with a kappa coefficient and further training will be done until a prevalence and bias-adjusted kappa >0.6 is achieved.
Based on historical administrative data, the number of pediatric MH visits at the pediatric specialized center is expected to be approximately 2250 during each 9-month period. This sample size will permit estimation of a proportion at this site to within±2.1 %, conservatively assuming a true proportion of 50 %. At the other extreme, the lowest number of pediatric MH visits during each 9-month period among the other three sites is expected to be approximately 61 at the rural hospital, which will permit estimation of a proportion to within ±12.5 %. Pooling across sites, the total sample size in each 9-month period is anticipated to be approximately 2503, which will permit estimation of a proportion to within±2.0 %.
Administrative databases will be used to evaluate whether the pathway improves health care coordination and decreases subsequent ED utilization and wait times. We will use NACRS data from each hospital to assess ED length of stay, hospital admissions, and number and frequency of repeat ED visits at 10 days and 3 months post the index ED visit. Data will be prospectively collected into a shared ED-CMHA database tool to assess CMHA service times (intake, full assessment and treatment) post-ED visit.
Patient/caregiver surveys will be used to assess satisfaction with the ED visit and service within CMHAs. Because the EDMHCP recommends CMHA referral intake within 7 days, we will use structured interviews and validated measures to conduct a 10-day post-ED visit survey to assess ED visit satisfaction and whether CMHA intake has occurred. Patients or their caregivers will be contacted by e-mail, post, or phone within 7–10 days of the ED visit and will be given three follow-up measures by phone: (1) structured interview to determine if patients had initiated and received recommended MH services 10 days after being discharged from the ED; (2) the eight-item Client Satisfaction Questionnaire (CSQ-8) to determine patients’ satisfaction with heath care services received in the ED as reported by caregivers or youth; and (3) The Services for Children and Adolescent-Parent Interview (SCA-PI) which describes pediatric MH services received across multiple settings, as reported by caregivers. To reduce respondent burden, for the purpose of this study, only eight questions concerning services received for MH issues have been selected. The SCA-PI will be used to measure patients’ use of community resources and document perceptions of the ED’s role in connecting them to MH services.
To explore reasons for potential variation across in implementation effectiveness across the study sites, we will conduct a concurrent process evaluation by documenting characteristics of our intervention, as well as the participants’ response to the delivery. This evaluation will assess the degree of variability and fidelity in implementation across the sites, revealing the degree to which the intervention addressed the relevant factors for change. Specific components of this process evaluation will include process logs, data from the post-implementation site visits, and qualitative interviews. Reasons for lack of completed implementation, should this occur at any site, will be detailed and further explored in the post-implementation phase interviews. Lessons learned will be documented and shared with site partners to promote sustained pathway use.
A process log will be used to longitudinally track key outcomes and capture issues related to site customization of documents, barriers and delays, workshop attendance and interest, ease of use, and degree of pathway uptake. Log components will include interim survey feedback, monthly updates from site champions, and implementation progress with negotiated target dates. Additional site support will be provided as needed, based on interim findings.
Two months following completed implementation, structured site visits will be conducted to assess accessibility and operational knowledge regarding the pathway. Findings will be compared to pre-implementation visits for each site.
To explore organizational issues, team dynamics and other relevant issues impacting EDMHCP implementation, post-implementation interviews will be held using TDF-based interview guides. On-site focus groups will be held with up to ten participants per organization. The focus group moderator will record field note observations. As well, KI interviews will be conducted with an administrative lead for each organization. Additional focus group sessions or KI interviews will be held if data saturation is not achieved. All interview sessions will be audiotaped and transcribed for analysis.
Descriptive statistics (means and standard deviations for continuous variables or medians with interquartile ranges) will summarize EDs, CMHAs, and patient characteristics. Frequencies and proportions for categorical variables will be reported. We will use a multiple baseline study design and conduct interrupted time-series analysis using segmented regression models, adjusting for site, with ARIMA autocorrelation structure [25–27] to evaluate whether the EDMHCP has resulted in improved health care utilization, medical management, and health sector coordination. Two-sided p values less than 0.05 will be considered statistically significant. Model estimates will be tabulated, together with 95 % confidence intervals. We will also calculate hospital level summary measures including proportions in the pre- and post-intervention periods at each site and referred to each CMHA. An unweighted mean of the change from pre- to post-intervention will be calculated for each hospital ED. The main effect measure will be calculated as the difference between the mean changes in intervention.
Qualitative analysis is integral to determine relevant factors and experience with EDMHCP use. Pre/post-site visits, focus groups, and KI interviews will yield complex data that will inform the intervention and prepare for the EDMHCP implementation (pre) and verify EDMHCP uptake status and assess stakeholders’ experiences regarding the intervention success. Interviews will be audiotaped and transcribed. Using the TDF, two coders will independently analyze all transcripts and field notes. The analyses will be provided in an overall thematic format prior to the intervention and 6-month post-intervention. To monitor progress and pursue emerging themes, data collection and analysis will proceed iteratively and concurrently . The qualitative analyst will feed relevant emerging themes back to the interviewer who will revise the interview guide as needed to capture new ideas. Inductive analysis will be managed using N-Vivo10 software and will occur in three phases: coding, using the TDF , and categorizing/developing themes. For consistent application, codes will be operationally defined and placed into broad categories that correspond to the major units of analysis. As categories emerge, their theoretical properties will be defined. Comparisons between multiple categories will be conducted to locate similarities and differences between them. Categories will then be synthesized into themes.
Ethics approval for this study has been granted at the coordinating site (Children’s Hospital of Eastern Ontario Research Ethics Board – CHEOREB# 15/146X). Prior to implementation within each dyad, REB approval will be obtained for each site hospital and CMHA. Informed consent will be sought for interviews and focus group meetings. All research data will be stored on a secure server. This trial is registered with ClinicalTrials.gov (NCT02590302).
This project is currently in the pre-implementation phase, seeking local ethics approvals and data sharing agreement, and preparing the intervention strategy.
By operationalizing best evidence into ED practices and formulating ED-CMHA partnerships through explicit agreements, the EDMHCP is poised to address current system gaps in addressing mental health for youth. This clinical pathway will standardize language and care provided through improved communication and explicit expectations for transition between ED and CMHA settings. Our evaluation will also rigorously address requirements for success and inform scalability to other settings. Our research will identify effective strategies to inform EDMHCP adoption in any community and provide knowledge on its impact by evaluating service integration improvements for this vulnerable population.
While trials are more typically conducted with a complete intervention strategy specified in advance, the unique nature of our proposed implementation requires rich understanding of professional and system issues within each organizational context. Hence, the importance of incorporating findings from our qualitative interviews and site visits to optimize likelihood of implementation success.
Important aspects of our tailored intervention strategy include opportunities for providers at each site to identify strengths and barriers to EDMHCP implementation and the deliberate plan to include site leads in the modification process from the beginning. The planned site visits, qualitative interviews, and continued communication will be helpful in generalizing the pathway implementation to other ED and CMHA settings of various sizes, staff, and urban/rural locations. Further, the tailored resources hosted on the HEADS-ED website  will be helpful reinforcement for sites that experience a high staff turnover, particularly for new ED residents and staff.
Given the complexity and novel aspects of this intervention, we anticipate some challenges in promoting modifications to current workflows. Each dyad contains the often hectic and somewhat unpredictable ED environment and the variability among CMHAs in their capacity and structure. Additionally, EDs and CMHAs do not typically interact closely, despite the shared patient population that moves between their settings. Other real-life issues such as budget restrictions, staff turnover, and competing project priorities have also been considered in setting our project timelines. At this stage, these issues are not prohibitive for any of our proposed study sites; however, this is always subject to change. Such is the challenge of implementation research.
Our study findings will be relevant for health systems and professionals responsible for ensuring standardized, quality care for children, and youth with acute MH concerns. To ensure our findings directly impact relevant service delivery areas, we have specifically recruited study team members with decision-making authority and/or influence on delivery of care for children and youth with MH concerns. We expect the protocol and findings can be customized and implemented in other EDs and CMHA settings. Equally important, this project will contribute further to implementation evidence relevant to use of clinical pathways and use of theory-based change strategies.
CHEO, Children’s Hospital of Eastern Ontario; CMHA, community mental health agency; CSQ-8, client satisfaction questionnaire; ED, emergency department; EDMHCP, Emergency Department Mental Health Clinical Pathway; HEADS-ED, screening tool that includes home, education, activities, drugs, suicidality, emotions, and discharge resources; KI, key informant (interviews); MH, mental health; NACRS, National Ambulatory Care Reporting System; REB, Research Ethics Board; SCA-PI, services for children and adolescents-parent interview; TDF, Theoretical Domains Framework
We are grateful to the Canadian Institutes of Health Research (CIHR) and the Ministry of Health and Long-Term Care (MOHLTC) for their financial support of this project. We would like to acknowledge Nathalie Thibedeau for her contributions to the original grant submission. We would also like to thank our hospital site partners, community agency partners, and knowledge users for their letters of support.
The funding source in support of this protocol includes a CIHR (#337794) and MOHLTC (#6719) Partnerships for Health Systems Improvement Grant, June 2015 to June 2018. These funding bodies had no role in the study design, data collection, analysis, interpretation, nor writing of the manuscript.
MJ co-chaired the provincial working group to develop this ED clinical pathway. MJ’s clinical pathway protocol  was adapted for the current study. MJ, MC, PC, RZ, SR, AK, CG, RZ, and WG contributed to the adaptation of the clinical protocol and the design of the study. CP drafted of the manuscript based on the original protocol. NB conducted the sample size calculations. All authors read, contributed to, and approved the final manuscript.
The team includes clinical and research expertise in emergency department clinical pathways (MJ), emergency medicine (MJ, SR, RZ), community- and hospital-based pediatric MH (MC, PC, KP, AK, CG, RZ, CP), biostatistics and statistical methodology (NB, WG), scoring tool development (MC, PC, RZ, AK, CG, WG), emergency outreach (SR), community outreach (AK, KP), and knowledge translation (MJ, MC, PC, AK, KP, RZ, CP).
The authors declare that they have no competing interests.
Ethics approval for this study has been granted at the coordinating site (Children’s Hospital of Eastern Ontario Research Ethics Board – CHEOREB# 15/146X). Prior to implementation within each dyad, REB approval will be obtained for each site hospital and CMHA. Informed consent will be sought for interviews and focus group meetings.